# US 2021/0275359 A1 · Microneedle Adhesive Patch Based on Hydrogel Formulation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275359 A1
- Document ID: US20210275359A1
- Status: Published application
- Kind: A1
- Application number: 17/056,340
- Filed: 2019-05-17
- Published: 2021-09-09
- Earliest claimed: 2018-05-18
- Assignees: Postech Academy-Industry Foundation
- Applicants: Postech Academy-Industry Foundation
- Inventors: Hyung Joon Cha; Eun Young Jeon; Jung Ho Lee; Geun Bae Lim
- Web page: https://patentgrep.com/patent/US20210275359A1

## CPC

- A61L 15/32: Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin {(A61L15/225 takes precedence)}
- A61F 13/00063: {comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic (drug delivery dressings A61K9/70; chemical aspect of the additives A61L15/00)}
- A61F 13/023: {wound covering film layers without a fluid retention layer}
- A61F 13/0246: characterised by the skin-adhering layer
- A61K 9/0021: {Intradermal administration, e.g. through microneedle arrays or needleless injectors}
- A61L 15/28: Polysaccharides or their derivatives {(A61L15/225 takes precedence)}
- A61L 15/42: Use of materials characterised by their function or physical properties (liquid bandages A61L26/00)
- A61L 15/58: Adhesives
- A61L 15/585: {Mixtures of macromolecular compounds}
- A61L 15/60: Liquid-swellable gel-forming materials, e.g. super-absorbents
- A61L 15/64: specially adapted to be resorbable inside the body
- A61M 37/0015: {by using microneedles}
- A61F 2013/00451: {for surgical sutures, e.g. butterfly type}
- A61F 2013/00676: {hydrogel}
- A61F 2013/00906: {for transcutaneous or transdermal drugs application}
- A61F 2013/0296: {for making transdermal patches (chemical processes excluded)}
- A61M 2037/0023: {Drug applicators using microneedles}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Disclosed are a microneedle patch including a first hydrogel layer containing a mussel adhesive protein and hyaluronic acid, and a second hydrogel layer containing silk fibroin, and a preparation method thereof. The microneedle patch according to the present disclosure has excellent tissue adhesion, biocompatibility, and biodegradability, and is used for transdermal drug delivery to promote wound regeneration.

## Claims

### Claim 1

A microneedle patch comprising:
a first hydrogel layer containing a mussel adhesive protein and hyaluronic acid; and
a second hydrogel layer containing silk fibroin.

### Claim 2 (depends on 1)

The microneedle patch of claim 1, wherein the mussel adhesive protein includes a protein having an amino acid sequence selected from a group consisting of amino acid sequences represented by SEQ ID NO: 1, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7 and SEQ ID NO: 8, or a fusion protein to which at least one amino acid sequence selected from the group is linked.

### Claim 3 (depends on 2)

The microneedle patch of claim 2, wherein the fusion protein includes a fusion protein having an amino acid sequence selected from a group consisting of amino acid sequences represented by SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13 and SEQ ID NO: 15.

### Claim 4 (depends on 2)

The microneedle patch of claim 2, wherein the fusion protein includes a fusion protein having the amino acid sequence represented by SEQ ID NO: 9 or SEQ ID NO: 15.

### Claim 5 (depends on 1)

The microneedle patch of claim 1, wherein the first hydrogel layer and the second hydrogel layer are cross-linked with each other.

### Claim 6 (depends on 1)

The microneedle patch of claim 1, wherein a content of the mussel adhesive protein is in a range of 25 to 50% (w/v) based on the first hydrogel layer.

### Claim 7 (depends on 1)

The microneedle patch of claim 1, wherein the hyaluronic acid has an average molecular weight of 40 kDa to 150 kDa.

### Claim 8 (depends on 1)

The microneedle patch of claim 1, wherein a content of the hyaluronic acid is in a range of 5 to 20% (w/v) based on the first hydrogel layer.

### Claim 9 (depends on 1)

The microneedle patch of claim 1, wherein a content of the silk fibroin is in a range of 40 to 70% (w/v) based on the second hydrogel layer.

### Claim 10 (depends on 1)

The microneedle patch of claim 1, wherein a ratio between a thickness of the first hydrogel layer and a thickness of the second hydrogel layer is in a range of 2:8 to 8:2.

### Claim 11 (depends on 1)

A tissue adhesive including the microneedle patch according to claim 1.

### Claim 12

A method of treating a wound of a patient, the method comprising:
contacting a microneedle patch with the wound of the patient, wherein the microneedle patch includes: a first hydrogel layer containing a mussel adhesive protein and hyaluronic acid; and a second hydrogel layer containing silk fibroin.

### Claim 13

(canceled)
